Marketing and sales solutions (MASS) is an independent management consultancy, dedicated to ensuring our clients achieve high performance through strategic brand development and implementation excellence. Focused on the pharmaceutical and health-care industries, our objective is to add straight to your bottom line. MASS has two primary areas of focus: Strategic Consulting and Implementation Excellence.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Company Details
Latest Content from PMHub
Press Releases | December 4, 2023 | Medscape Education
How can the patient’s voice improve care?This was the question Medscape Oncology Clinical Strategist Victoria Harvey-Jones, PhD and Lesley Fallowfield DBE, BSC, DPHIL, FMEDSCI, Professor of Pyscho-Oncology, Sussex Health Outcomes...
White Papers and Resources | December 1, 2023 | Impetus Digital
Authentic patient engagement and insight-gathering are becoming must-haves in Pharma. However, multiple obstacles remain before patient-centricity becomes more than a buzzword. In our latest playbook, we take a deep dive...
Press Releases | November 30, 2023 | Medscape Education
December 1 marks the 35th year commemorating World AIDS Day, and the theme is “Remember and Commit.” While new infections have steadily declined over the last several years, HIV remains a...
Videos and Podcasts | November 30, 2023 | Impetus Digital
Here's another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #9. No More “White Space” Between Live Meetings Clearly, the...
Press Releases | November 30, 2023 | Graphite Digital
Key takeaways from the perspectives of industry experts across medical, commercial and digital on the issue of trust in pharma and how this impacts HCP engagement.
Press Releases | November 28, 2023 | Medscape Education
What are the qualities needed to be a leader in the medical field of oncology?Of course, you must be a good clinician. But you also have to be wise and...
Press Releases | November 28, 2023 | Petauri Evidence
Specialised commissioning continues to be an issue of significance and uncertainty for both the NHS and industry. What do the latest reports of regional push back on the plans for...
Press Releases | November 28, 2023 | EPG Health
EPG Health wins Excellence in Engagement through Digital Channels award at PMEA 2023
Press Releases | November 27, 2023 | Medscape Education
On November 8-9, Medscape Education held the 2nd Annual Women’s Health Master Class—Modernizing Women's Health: Elevating Quality Care for Everyday Practice, two days dedicated to bringing the latest advances in...
White Papers and Resources | November 27, 2023 | Impetus Digital
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access.